Outlook Therapeutics, Inc. (OTLK) › Cash & EquivalentsOutlook Therapeutics, Inc. (OTLK) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2014-09-30: $2.35M2015-09-30: $9.07M2016-09-30: $2.35M2017-09-30: $3.19M2018-09-30: $1.72M2019-09-30: $8.02M2020-09-30: $12.54M2021-09-30: $14.48M2022-09-30: $17.40M2023-09-30: $23.39M2024-09-30: $14.93M2025-09-30: $8.08M$8.08M2014-09-30Cash & Equivalents (USD)2025-09-30Period endedCash & EquivalentsChange YoYSource filing2025-09-30$8.08M-45.9%2025-12-19Balance as of period end2024-09-30$14.93M-36.2%2025-12-19Balance as of period end2023-09-30$23.39M+34.5%2024-12-27Balance as of period end2022-09-30$17.40M+20.2%2023-12-22Balance as of period end2021-09-30$14.48M+15.5%2022-12-29Balance as of period end2020-09-30$12.54M+56.4%2021-12-23Balance as of period end2019-09-30$8.02M+366.7%2020-12-23Balance as of period end2018-09-30$1.72M-46.1%2019-12-19Balance as of period end2017-09-30$3.19M+35.4%2018-12-18Balance as of period end2016-09-30$2.35M-74.1%2018-12-18Balance as of period end2015-09-30$9.07M+286.1%2017-12-29Balance as of period end2014-09-30$2.35M—2016-12-29Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)